Current Aging Science
Title:Looking Towards New Pathogenetic Mechanisms in Parkinson’s Disease: is ANT1 the Potential Candidate?
Volume: 11 Issue: 1
Author(s): Antonino Naro, Vincenzo Cimino, Simona Portaro and Rocco S. Calabro*
Affiliation:
- IRCCS Centro Neurolesi "Bonino-Pulejo" S.S. 113, Contrada Casazza, 98124, Messina,Italy
Export Options
About this article
Cite this article as:
Naro Antonino , Cimino Vincenzo , Portaro Simona and Calabro S. Rocco *, Looking Towards New Pathogenetic Mechanisms in Parkinson’s Disease: is ANT1 the Potential Candidate?, Current Aging Science 2018; 11 (1) . https://dx.doi.org/10.2174/187460981101180727150022
DOI https://dx.doi.org/10.2174/187460981101180727150022 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis Current Drug Targets for Modulating Alzheimer's Amyloid Precursor Protein: Role of Specific Micro-RNA Species
Current Medicinal Chemistry Future Therapeutic Directions: New Medications and Insulin Delivery in a Changing World for Effective Diabetes Management
Current Drug Discovery Technologies Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy Editorial [Hot Topic: Mitochondria as a Pharmacological Target: A Clue for Efficacy and a Reason for Toxicity (Executive Guest Editor: Nadezda Apostolova)]
Current Pharmaceutical Design Nanotechnology and Alzheimer's Disease: What has been Done and What to Do'
Current Medicinal Chemistry Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders
Current Molecular Medicine Patent Selections
Recent Patents on Food, Nutrition & Agriculture Current Approaches for the Treatment with Thyroid Hormone Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Glutamate Transporter 1: Target for the Treatment of Alcohol Dependence
Current Medicinal Chemistry The Antioxidant Response as a Drug Target in Diabetic Neuropathy
Current Drug Targets Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration
Current Neuropharmacology Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
Current Neuropharmacology Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases
Central Nervous System Agents in Medicinal Chemistry Synthetic and Natural Products as Iron Chelators
Current Topics in Medicinal Chemistry CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry Astrocytes and Gliotransmitters: New Players in the Treatment of Major Depression?
Current Drug Targets Biomarkers in Amyotrophic Lateral Sclerosis: Is There A Neurovascular Pathway?
Current Neurovascular Research